Viewing nowCreazin 20mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

MFDS item code 201400411 · Approved 2014.01.29 · Insurance code 642403850
Improvement of dyslipidemia, prevention of cardiovascular disease, and inhibition of atherosclerosis progression
This medication is used in patients with primary hypercholesterolemia and mixed dyslipidemia when diet and exercise alone do not adequately control lipid levels. It may also assist patients with homozygous familial hypercholesterolemia when used in conjunction with dietary therapy or other lipid-lowering therapies. It is effective in lowering total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, thereby helping to slow the progression of atherosclerosis. It is also used as an adjunct to dietary therapy for pediatric patients who meet specific criteria for heterozygous familial hypercholesterolemia. Additionally, it aids in dietary management for patients with primary dysbetalipoproteinemia. Furthermore, it is effective in reducing the risk of stroke, myocardial infarction, and arterial revascularization in adults at high risk for cardiovascular diseases. This medication improves dyslipidemia and the associated risk of cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug, and continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: No dosage adjustment is necessary. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this drug to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this drug is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be individualized according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. First, individuals who have had an allergic reaction to this medication must not take it. Patients with active liver disease or significantly elevated liver enzyme levels should also avoid this product. Patients with muscle disorders, those taking cyclosporine, or those with severely impaired renal function should refrain from using this medication. Special caution is required for pregnant or breastfeeding women and for women of childbearing age not using adequate contraception; it should only be used if the potential risk to the fetus is thoroughly explained. High-dose administration is particularly prohibited in patients at risk for myopathy or rhabdomyolysis. Additionally, patients with lactose intolerance or related genetic disorders should not take this medication. This medication should be used cautiously in patients with a history of alcohol overconsumption or liver disease, with frequent liver function tests conducted. If there are underlying conditions such as hypothyroidism or nephrotic syndrome, these conditions should be addressed prior to treatment. Muscle-related side effects may rarely occur; therefore, if muscle pain, weakness, or cramps occur, the patient should notify the physician immediately, and blood tests may be necessary to check for muscle damage. Particularly elderly patients, those with renal impairment, or those with a history of alcohol abuse, who are at higher risk for muscle side effects, should be closely monitored. This medication can also affect liver function, potentially increasing liver enzyme levels, so regular liver function testing is recommended. Rarely, severe liver damage or skin reactions may occur; if symptoms such as skin rash or jaundice appear, the patient should stop taking the medication and consult their doctor immediately. This medication may interact with other drugs; therefore, any co-administered medications should be reported to the healthcare provider. Specifically, concomitant use with some antiviral agents, immunosuppressants, antifungals, antibiotics, and fibrate-class drugs may increase the risk of muscle side effects. Moreover, when taken with antacids, this medication's absorption may decrease, so spacing the dosing is advisable. Pregnant or breastfeeding women should not take this medication, and women of childbearing age should employ appropriate contraceptive methods. If taken during pregnancy, it may be harmful to the fetus, and usage should cease immediately upon confirmation of pregnancy. In the case of overdose, there is no specific antidote, thus treatment should focus on symptomatic relief and monitoring of liver function and muscle enzyme levels. This medication is not known to significantly affect driving or operating machinery, but caution should be exercised as dizziness may occur. Finally, this medication may show higher concentrations in Asian individuals, possibly necessitating dose adjustments. Although its efficacy and safety in pediatric patients is similar to that in adults, monitoring for growth and secondary sexual characteristics is required.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, fixed-drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to avoid exposure to air and moisture and kept at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a longer duration.
Pink round film-coated tablet
28 tablets/Alu-Alu PTP (7 tablets/Alu-Alu PTP*4)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.